versão On-line ISSN 2078-5151
versão impressa ISSN 0038-2361
S. Afr. j. surg. vol.49 no.3 Cape Town Ago. 2011
A. N. MorksI; T. M. van GinhovenII; J. M. PekelharingIII; E. J. J. DuschekIV; P. C. SmitV; P. W. de GraafV
IM.D.; Department of Surgery, Reinier de Graaf Hospital, Delft, The Netherlands
IIM.D.; Ph.D.Department of Surgery, Erasmus MC, Rotterdam, The Netherlands
IIIM.D.; Ph.D.Department of Clinical Chemistry, Reinier de Graaf Hospital
IVM.D.; Ph.DDepartment of Endocrinology, Reinier de Graaf Hospital
VM.D.; Ph.D.Department of Surgery, Reinier de Graaf Hospital
BACKGROUND: Surgery is the treatment of choice for symptomatic primary hyperparathyroidism. The majority of research concerning intra-operative parathyroid hormone (ioPTH) measurements is conducted in university hospitals. Whether ioPTH measurements are feasible and useful in predicting the presence of remaining hyperfunctioning parathyroid tissue in a non-academic hospital remains uncertain.
METHODS: Data were collected on all patients with biochemically proven and surgically treated primary hyperparathyroidism treated at the Reinier de Graaf Hospital from August 2002 to December 2007.
RESULTS: Sixty-five patients were included. The mean pre-operative serum calcium level was 2.78 mmol/l (range 2.28 - 3.80 mmol/l, normal range 2.20 - 2.65 mmol/l) and the mean serum parathyroid hormone level 17.0 pmol/l (range 4.0 - 90.3 pmol/l, normal range 1.0 - 5.5 pmol/l). All patients were operated on for primary hyperparathyroidism, using ioPTH measurements during their first operation. Sensitivity and specificity rates of ioPTH measurements were 98% and 89%, respectively. The ioPTH test accurately indicated incomplete removal of all hyperfunctioning parathyroid tissue in 8 patients (12%). Five patients (8%) were re-explored immediately, of whom 4 were successfully treated in this single operative session. One patient was operated on successfully the next day. Two patients were operated on with a successful result during a second admission. In all the ioPTH measurements there was 1 false-positive result (1.5%) and 1 false-negative result (1.5%).
The mean postoperative calcium value for the successfully treated patients was 2.34 mmol/l (range 2.14 - 2.71 mmol/l, normal range 2.20 - 2.65 mmol/l). The mean postoperative PTH level for the successfully treated patients was 3.76 pmol/l (range 0.40 - 7.1 pmol/l).
CONCLUSION: Our data suggest that ioPTH measurements are feasible and useful in a non-academic hospital.
“Full text available only in PDF format”
1. Sitges-Serra A, Bergenfelz A. Clinical update: sporadic primary hyperparathyroidism. Lancet 2007;370:468-470. [ Links ]
2. Lee JA, Inabnet WB 3rd. The surgeon's armamentarium to the surgical treatment of primary hyperparathyroidism. J Surg Oncol 2005;89(3):130-135. [ Links ]
3. Ruda JM, Hollenbeak CS, Stack BC Jr. A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003. Otolaryngol Head Neck Surg 2005;132(3):359-372. [ Links ]
4. Bergenfelz A, Kanngiesser V, Zielke A, Nies C, Rothmund M. Conventional bilateral cervical exploration versus open minimally invasive parathyroidectomy under local anaesthesia for primary hyperparathyroidism. Br J Surg 2005;92(2):190-197. [ Links ]
5. Bergenfelz A, Lindblom P, Tibblin S, Westerdahl J. Unilateral versus bilateral neck exploration for primary hyperparathyroidism: a prospective randomized controlled trial. Ann Surg 2002;236(5):543-551. [ Links ]
6. Udelsman R. Six hundred fifty-six consecutive explorations for primary hyperparathyroidism. Ann Surg 2002;235(5):665-670; discussion 670-672. [ Links ]
7. Smit PC, Borel Rinkes IH, van Dalen A, van Vroonhoven TJ. Direct, minimally invasive adenomectomy for primary hyperparathyroidism: An alternative to conventional neck exploration? Ann Surg 2000;231(4):559-565. [ Links ]
8. Russell CF, Dolan SJ, Laird JD. Randomized clinical trial comparing scan-directed unilateral versus bilateral cervical exploration for primary hyperparathyroidism due to solitary adenoma. Br J Surg 2006;93(4):418-421. [ Links ]
9. Davies C, Demeure MJ, St John A, Edis AJ. Study of intact (1-84) parathyroid hormone secretion in patients undergoing parathyroidectomy. World J Surg 1990;14(3):355-359; discussion 360. [ Links ]
10. de Vos tot Nederveen Cappel R, Bouvy N, de Herder W, de Rijke Y, van Toor H, Bonjer J. Novel criteria for parathyroid hormone levels in parathyroid hormone- guided parathyroid surgery. Arch Pathol Lab Med 2007;131(12):1800-1804. [ Links ]
11. Carneiro DM, Solorzano CC, Nader MC, Ramirez M, Irvin GL 3rd. Comparison of intraoperative iPTH assay (QPTH) criteria in guiding parathyroidectomy: which criterion is the most accurate? Surgery 2003;134(6):973-979; discussion 979-981. [ Links ]
12. Weber KJ, Misra S, Lee JK, Wilhelm SW, DeCresce R, Prinz RA. Intraoperative PTH monitoring in parathyroid hyperplasia requires stricter criteria for success. Surgery 2004;136(6):1154-1159. [ Links ]
13. Smit PC, Thijssen JH, Borel Rinkes IH, van Vroonhoven TJ. [Peroperative parathyroid hormone assay: assurance of successful surgical treatment of primary hyperparathyroidism] Peroperatieve parathormoonbepaling: zekerstelling van geslaagde chirurgische behandeling van primaire hyperparathyreoidie. Ned Tijdschr Geneeskd 1999;143(14):742-746. [ Links ]
14. Clerici T, Brandle M, Lange J, Doherty GM, Gauger PG. Impact of intraoperative parathyroid hormone monitoring on the prediction of multiglandular parathyroid disease. World J Surg 2004;28(2):187-192. [ Links ]
15. Fuchs SP, Smits AB, de Hooge P, Muller AF, Gelissen JP, van Dalen T. [Minimally-invasive parathyroidectomy: a good operative procedure for primary hyperparathyroidism even without the use of intraoperative parathyroid-hormone assessment or a gamma probe] Minimaal invasieve parathyreoidectomie: ook zonder het gebruik van intraoperatieve parathormoonmeting of gammaprobe een goede behandeling voor primaire hyperparathyreoidie. Ned Tijdschr Geneeskd 2005;149(26):1463-1467. [ Links ]
16. Sathe PA, Madiwale CV, Kandalkar BM, Bandgar TR, Shah NS, Menon PS. Primary hyperparathyroidism: a clinicopathological experience. Indian J Pathol Microbiol 2009;52(3):313-120. [ Links ]
17. Johnson SJ, Sheffield EA, McNicol AM. Best practice no 183. Examination of parathyroid gland specimens. J Clin Pathol 2005;58(4):338-342. [ Links ]
18. Halevy A, Stepansky A, Halpern Z, et al. Quick parathormone assay in the surgical management of hyperparathyroidism. Isr Med Assoc J 2003;5(11):775-777. [ Links ]
19. Mozzon M, Mortier PE, Jacob PM, Soudan B, Boersma AA, Proye CA. Surgical management of primary hyperparathyroidism: the case for giving up quick intra-operative PTH assay in favor of routine PTH measurement the morning after. Ann Surg 2004;240(6):949-953; discussion 953-954. [ Links ]
20. Carneiro-Pla DM, Solorzano CC, Irvin GL 3rd. Consequences of targeted parathyroidectomy guided by localization studies without intraoperative parathyroid hormone monitoring. J Am Coll Surg 2006;202(5):715-722. [ Links ]
21. Gil-Cardenas A, Gamino R, Reza A, Pantoja JP, Herrera MF. Is intraoperative parathyroid hormone assay mandatory for the success of targeted parathyroidectomy? J Am Coll Surg 2007;204(2):286-290. [ Links ]
22. Pang T, Stalberg P, Sidhu S, et al. Minimally invasive parathyroidectomy using the lateral focused mini-incision technique without intraoperative parathyroid hormone monitoring. Br J Surg 2007;94(3):315-319. [ Links ]
23. Jacobson SR, van Heerden JA, Farley DR, et al. Focused cervical exploration for primary hyperparathyroidism without intraoperative parathyroid hormone monitoring or use of the gamma probe. World J Surg 2004;28(11):1127-1131. [ Links ]
24. Mihai R, Palazzo FF, Gleeson FV, Sadler GP. Minimally invasive parathyroidectomy without intraoperative parathyroid hormone monitoring in patients with primary hyperparathyroidism. Br J Surg 2007;94(1):42-47. [ Links ]